Mello Stephano S, Sinow Carolyn, Raj Nitin, Mazur Pawel K, Bieging-Rolett Kathryn, Broz Daniela Kenzelmann, Imam Jamie F Conklin, Vogel Hannes, Wood Laura D, Sage Julien, Hirose Tetsuro, Nakagawa Shinichi, Rinn John, Attardi Laura D
Department of Radiation Oncology, Stanford University School of Medicine, Stanford, California 94305, USA.
Department of Pediatrics, Stanford University School of Medicine, Stanford, California 94305, USA.
Genes Dev. 2017 Jun 1;31(11):1095-1108. doi: 10.1101/gad.284661.116. Epub 2017 Jul 11.
The gene is mutated in over half of all cancers, reflecting its critical role as a tumor suppressor. Although p53 is a transcriptional activator that induces myriad target genes, those p53-inducible genes most critical for tumor suppression remain elusive. Here, we leveraged p53 ChIP-seq (chromatin immunoprecipitation [ChIP] combined with high-throughput sequencing) and RNA-seq (RNA sequencing) data sets to identify new p53 target genes, focusing on the noncoding genome. We identify , a noncoding RNA (ncRNA) constituent of paraspeckles, as a p53 target gene broadly induced by mouse and human p53 in different cell types and by diverse stress signals. Using fibroblasts derived from mice, we examined the functional role of in the p53 pathway. We found that is dispensable for cell cycle arrest and apoptosis in response to genotoxic stress. In sharp contrast, plays a crucial role in suppressing transformation in response to oncogenic signals. deficiency enhances transformation in oncogene-expressing fibroblasts and promotes the development of premalignant pancreatic intraepithelial neoplasias (PanINs) and cystic lesions in Kras-expressing mice. loss provokes global changes in gene expression, suggesting a mechanism by which its deficiency promotes neoplasia. Collectively, these findings identify as a p53-regulated large intergenic ncRNA (lincRNA) with a key role in suppressing transformation and cancer initiation, providing fundamental new insight into p53-mediated tumor suppression.
该基因在超过半数的癌症中发生突变,这反映了其作为肿瘤抑制因子的关键作用。尽管p53是一种诱导众多靶基因的转录激活因子,但对肿瘤抑制最为关键的那些p53诱导基因仍不清楚。在这里,我们利用p53染色质免疫沉淀测序(ChIP-seq,染色质免疫沉淀[ChIP]与高通量测序相结合)和RNA测序(RNA-seq)数据集来鉴定新的p53靶基因,重点关注非编码基因组。我们鉴定出一种副斑点的非编码RNA(ncRNA)成分,它是小鼠和人类p53在不同细胞类型中以及在多种应激信号作用下广泛诱导的p53靶基因。利用来自p53基因敲除小鼠的成纤维细胞,我们研究了该基因在p53通路中的功能作用。我们发现,在对基因毒性应激的反应中,该基因对于细胞周期停滞和凋亡是可有可无的。与之形成鲜明对比的是,在对致癌信号的反应中,该基因在抑制细胞转化中起关键作用。该基因缺陷增强了表达癌基因的成纤维细胞的转化能力,并促进了表达Kras的小鼠中癌前胰腺上皮内瘤变(PanINs)和囊性病变的发展。该基因缺失引发基因表达的全局变化,提示了其缺陷促进肿瘤形成的一种机制。总体而言,这些发现鉴定出该基因是一种p53调控的长链基因间非编码RNA(lincRNA),在抑制细胞转化和癌症起始中起关键作用,为p53介导的肿瘤抑制提供了全新的基本认识。